Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;19(4):91-5.
doi: 10.1294/jes.19.91. Epub 2009 Jan 9.

Effect of Low-Dose Human Interferon-alpha on Shipping Fever of Thoroughbred Racehorses

Makoto Akai  1 , Seiji Hobo  2 , Shinya Wada  1
Affiliations

Effect of Low-Dose Human Interferon-alpha on Shipping Fever of Thoroughbred Racehorses

Makoto Akai et al. J Equine Sci. 2008.

Abstract

To assess the effect of human interferon-alpha (IFNα) on shipping fever of Thoroughbred racehorses subjected to long-distance transportation, an IFNα preparation was orally administered to 48 horses three times (once daily, 3 successive days) before transportation (IFNα group). In the control group (25 horses), maltose was administered in the same way. These treatments induced no abnormal findings in Thoroughbred racehorses before transportation. Immediately after transportation, significant increases in rectal temperature were observed in both treatment groups, whereas the rectal temperature of the IFNα group tended to be lower than that of the control group. Although WBC, Fbg, and SAA immediately after transportation were significantly increased due to transportation in both groups, the extent of the increases in the IFNα group was significantly smaller than in the control group. Long-distance transportation had a relatively profound impact on Thoroughbred racehorses, which was mitigated by IFNα treatment.

Keywords: human interferon-alpha; low-dose; oral administration; shipping fever; thoroughbred racehorses.

PubMed Disclaimer

References

    1. Cummins J.M., Beilharz M.W., Krakowka S.1999. Oral use of interferon. J. Interferon Cytokine Res. 19: 853–857 - PubMed
    1. Eid P., Meritet J.F., Maury C., Lasfar A., Weill D., Tovey M.G.1999. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics. J. Interferon Cytokine Res. 19: 157–169 - PubMed
    1. Gutterman J.U.1994. Cytokine therapeutics: lessons from interferon alpha. Proc. Natl. Acad. Sci. USA 91: 1198–1205 - PMC - PubMed
    1. Hobo S., Oikawa M., Kuwano A., Yoshida K., Yoshihara T.1997. Effect of transportation on the composition of bronchoalveolar lavage fluid obtained from horses. Am. J. Vet. Res. 58: 531–534 - PubMed
    1. Hobo S., Tomita T., Nambo Y., Anzai T.2006. Preventive effect of low-dose interferon alpha oral medication against shipping fever in thoroughbreds. J. Jap. Vet. Assoc. 59: 741–745

LinkOut - more resources